Rationale Documents

Oritavancin​​ Rationale Document

Version 1.0, 2016

DOWNLOAD

Tedizolid​​ Rationale Document​

Version 1.0, 2016

DOWNLOAD

Dalbavancin Rationale Document

Version 1.1, 2018

DOWNLOAD

Telavancin Rationale Document

Version 1.0, 2016

DOWNLOAD

Reports

Quinolone In Vitro Susceptibility Test Interpretation Criteria Evaluations

Version 1.3, 2018

DOWNLOAD

Aminoglycoside In Vitro Susceptibility Test Interpretation Criteria Evaluations

Version 1.3, 2019

DOWNLOAD

Report on Method Validation and Susceptibility Breakpoint Criteria for Testing Gonococci

Version 1.0, 2019

DOWNLOAD

AST Guidance Document

USCAST Surrogate Guidance Testing Document

Version 1.1, 2018

DOWNLOAD